Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats

Carcinogenesis

Volumn 27, Issue 10, 2006, Pages 1970-1979

  Manjanatha, Mugimane ^a   Shelton, Sharon ^a   Bishop, Michelle ^a   Lyn Cook, Lascelles ^a   Aidoo, Anane ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLINE; DAIDZEIN; ESTRADIOL; GENISTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; ISOFLAVONE DERIVATIVE;

ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST ADENOMA; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; BREAST TUMOR; CANCER PREVENTION; CELL PROLIFERATION; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG MEGADOSE; DRUG MIXTURE; FEEDING; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MENOPAUSE; MUTAGENICITY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SOYBEAN; SPLEEN LYMPHOCYTE; STATISTICAL SIGNIFICANCE; TRANSGENIC ANIMAL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; BODY WEIGHT; DIET; FEMALE; GENISTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; ISOFLAVONES; LAC OPERON; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MUTATION; ORGAN SIZE; OVARIECTOMY; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED BB;

EID: 33749554772     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl028     Document Type: Article

References (57)

1. Messina,M.J., Persky,V., Setchell,K.D. and Barnes,S. (1994) Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr. Cancer, 21, 113-131.
2. Kennedy,A.R. (1995) The evidence for soybean products as cancer preventive agents. J. Nutr., 125, 733s-743s.
3. Barnes,S., Peterson,T.G. and Coward,L. (1995) Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J. Cell Biochem. Suppl., 22, 181-187.
4. Knight,D.C. and Eden,J.A. (1996) A review of the clinical effects of phytoestrogen. Obstet. Gynecol., 87, 897-904.
5. Kurzer,M.S. and Xu,X. (1997) Dietary phytoestrogens. Annu. Rev. Nutr., 17, 353-381.
6. Peterson,G. and Barnes,S. (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate, 22, 335-345.
7. Constantinou,A. and Huberman,E. (1995) Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action. Proc. Soc. Exp. Biol. Med., 208, 109-115.
8. Pommier,Y., Zwelling,L.A., Kao-Shan,C.S., Whang-Peng,J. and Bradly,M.O. (1985) Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations and cytotoxicity in Chinese hamster cells. Cancer Res., 45, 3143-3149.
9. Kaufmann,W.K. (1998) Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc. Soc. Exp. Biol. Med., 217, 327-334.
10. Kulling,S.E. and Metzler,M. (1997) Induction of micronuclei, DNA strand breaks and Hprt mutations in cultured Chinese hamster V79 cells by the phytoestrogen cummoestrol. Food Chem. Toxicol., 35, 605-613.
11. Morris,S.M., Chen,J.J., Domon,O.E., McGarrity,L.J., Bishop,M.E., Manjanatha,M.G. and Casciano,DA. (1998) P53, mutations, and apoptosis in genistein-exposed human lymphoblastoid cells. Mutat. Res., 405, 41-56.
12. Misra,R.R., Hursting,S.D., Perkins,S.N., Sathyamoorthy,N., Mirsalis,J.C., Riccio,E.S. and Crowell,J.A. (2002) Genotoxicity and carcinogeniciy studies of soy isoflavones. Intl. J. Toxicol., 21, 277-285.
13. Giri,A.K. and Lu,L.J.W. (1995) Genetic damage and inhibition of 7,12-dimethylbenz(a)anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein. Cancer Lett., 95, 125-133.
14. Rao,C.V., Wang,C.X., Siml,B., Lubet,R., Kelloff,G., Steele,V. and Reddy,B.S. (1997) Enhancement of experimental colon cancer by genistein. Cancer Res., 57, 3717-3722.
15. Day,J.K., Besch-Williford,C., McMann,T.R., Hufford,M.G., Lubahn,D.B. and MacDonald,R.S. (2001) Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice. Nutr. Cancer, 39, 226-232.
16. Allred,C.D., Allred,K.F., Ju,Y.H., Clausen,L.M., Doerge,D.R., Schantz,S.L., Korol,D.L., Wallig,M.A. and Helferich,W.G. (2004) Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis, 25, 211-218.
17. Abe,T. (1999) Infantile leukemia and soybean - a hypothesis. Leukemia, 13, 317-320.
18. Chen,Z., Zheng,W., Custer,L.J. et al. (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr. Cancer, 33, 82-87.
19. Arai,Y., Uehara,M., Sato,Y. et al. (2000) Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol., 10, 127-135.
20. Aidoo,A., Lyn-Cook,L.E., Mittelstaedt,R.A., Heflich,R.H. and Casciano,D.A. (1991) Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide. Environ. Mol. Mutagen., 17, 141-151.
21. Aidoo,A., Morris,S.M. and Casciano,D.A. (1997) Development and utilization of the rat lymphocyte Hprt mutation assay. Mutat. Res., 387, 69-88.
22. Manjanatha,M.G., Lyn-Cook,L.E., Culp,S.J., Beland,F.A., Heflich,R.H. and Aidoo,A. (1996) Lymphocyte mutant frequency in relation to DNA adduct formation in rats treated with tumorigenic doses of the mammary gland carcinogen 7,12-dimethylbenz[a]anthracene. Mutat. Res., 357, 89-96.
23. Manjanatha,M.G., Shelton,S.D., Aidoo,A., Lyn-Cook,L.E. and Casciano,D.A. (1998) Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue rats treated with 7,12-dimethylbenz[a]anthracene. Mutat. Res., 401, 165-178.
24. Manjanatha,M.G., Shelton,S.D., Culp,S.J., Blankenship,L.R. and Casciano,D.A. (2000) DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7,12-dimethylbenz(a)anthracene. Carcinogenesis, 21, 265-273.
25. Chen,T., Aidoo,A., Manjanatha,M.G., Mittelstaedt,R.A., Shelton,S.D., Lyn-Cook,L.E., Casciano,D.A. and Heflich,R.H. (1998) Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic LacI gene of Big Blue rats. Mutat. Res., 403, 199-214.
26. Leung,B.S., Sasaki,G.H. and Leung,J.S. (1975) Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors. Cancer Res., 35, 621-627.
27. Bradley,C.J., Kledzik,G.S. and Meites,J. (1976) Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development. Cancer Res., 36, 319-324.
28. Ip,C. and Ip,M.M. (1981) Serum estrogen and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat. J. Natl Cancer Inst., 66, 291-295.
29. Fu,X., Blaydes,B.S., Weis,C.C., Latendresse,J.R., Muskhelishvili,L., Sutter,T.R. and Delclos,K.B. (2003) Effects of dietary soy and estrous cycle on adrenal cytochrome p450 1B1 expression and DMBA metabolism in adrenal glands and livers in female Sprague-Dawley rats. Chem. Biol. Interact., 146, 273-284.
30. Russo,J., Gusterson,B.A., Rogers,A.E., Russo,I.H., Wellings,S.R. and van Zwieten,M.J. (1990) Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62, 244-278.
31. Dao,T.L. (1962) The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons. Cancer Res., 22, 973-981.
32. Welsch,C.W. (1985) Host factors affecting the growth of carcinogeninduced rat mammary carcinoma: A review and tribute to Charles Brenton Huggins. Cancer Res., 45, 3415-3443.
33. Allaben,W.T., Weis,C.C., Fullerton,N.F. and Beland,F.A. (1983) Formation and persistence of DNA adducts from the carcinogen N-hydroxy-2-acetylaminofluorene in rat mammary gland in vivo. Carcinogenesis, 4, 1067-1070.
34. Foley,J.F., Dietrich,D.R., Swenberg,J.A. and Maronpot,R.R. (1991) Detection and evaluation of proliferating cell nuclear antigen (PCNA) in rat tissue by an improved immunohistochemical procedure. J. Histotechnol., 14, 237-241.
35. Gavrieli,Y., Sherman,Y. and Ben-Sasson,S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol., 119, 493-501.
36. Albertazzi,P., Pansini,F., Bonaccorsi,G., Zanotti,L., Forini,E. and de Aloysio,D. (1998) The effect of dietary soy supplementation on hot flushes. Obstet. Gynecol., 91, 6-11.
37. Faure,E.D., Chantre,P. and Mares,P. (2002) Effects of a standardized soy extract on hot flushes: A multicenter, double-blind, randomized, placebocontrolled study. Menopause, 9, 329-334.
38. Harvell,D.M., Strecker,T.E., Tochacek,M., Xie,B., Pennington,K.L., McComb,R.D., Roy,S.K. and Shull,J.D. (2000) Rat strain-specific actions of 17 eta-estradiol in the mammary gland: Correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc. Natl Acad. Sci. USA, 97, 2779-2784.
39. Mehta,R.G., Bhat,K.P., Hawthorne,M.E., Kopelovich,L., Mehta,R.R., Christov,K., Kelloff,G.J., Steele,V.E. and Pezzuto,J.M. (2001) Induction of atypical ductal hyperplasia in mouse mammary gland organ culture. J. Natl Cancer Inst., 93, 1103-1106.
40. Teller,M.N., Kaufman,R.J., Bowie,M. and Stock,C.C. (1969) Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12- dimethylbenz(a)anthracene-induced rat mammary tumors. Cancer Res., 29, 349-352.
41. Bradley,C.J., Kledzik,G.S. and Meites,J. (1976) Prolactin and estrogen dependency in rat mammary cancer at later stages of development. Cancer Res., 36, 319-324.
42. McCormick,D.L., Mehta,R.G., Thompson,C.A., Dinger,N., Caldwell,J.A. and Moon,R.C. (1982) Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl) retinamide and ovariectomy. Cancer Res., 42, 508-512.
43. Ohi,Y. and Yoshida,H. (1992) Influence of estrogen and progesterone on the induction of mammary carcinomas by DMBA in ovariectomized rats. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol., 62, 365-370.
44. Adlercreutz,H. and Mazur,W. (1997) Phytoestrogens and Western diseases. Ann. Med., 29, 95-120.
45. Liehr,J.G. (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev., 21, 40-54.
46. Liehr,J.G. and Roy,D. (1990) Free radical generation by redox cycling of estrogens. Free Radic. Biol. Med., 8, 415-423.
47. Liehr,J.G., Roy,D., Ari-Ulubelen,A., Bui,Q.D., Weisz,J. and Strobel,H.W. (1990) Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catecholestrogens and their redox cycling: Implications for carcinogenesis. J. Steroid Biochem., 35, 555-560.
48. Han,X. and Liehr,J.G. (1994) 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen-induced carcinogenesis. Cancer Res., 54, 5515-5517.
49. Davis,D.L., Bradlow,H.L., Wolff,M., Woodruff,T., Hoel,D.G. and Anton-Culver,H. (1993) Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect., 101, 372-377.
50. Davis,D.L. and Bradlow,H.L. (1995) Can environmental estrogens cause breast cancer. Sci. Am., 273, 166-171.
51. Bradlow,H.L., Davis,D.L., Lin,G., Sepkovic,D. and Tiwari,R.K. (1995) The ratio of 16α/2-hydroxyestrone as a biologic marker of breast cancer risk. Environ. Health Perspect., 103, 147-150.
52. Nebert,D.W. (1993) Elevated estrogen 16 alpha-hydroxylase activity: Is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? J. Natl Cancer Inst., 85, 1888-1891.
53. Schneider,J., Kinne,D., Fracchia,A., Pierce,V., Anderson,K.E., Bradlow,H.L. and Fishman,J. (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl Acad. Sci. USA, 79, 3047-3051.
54. Bradlow,H.L., Hershcopf,R.J., Martucci,C.P. and Fishman,J. (1985) Estradiol 16α-hydroxylation in the mouse correlate with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans. Proc. Natl Acad. Sci. USA, 82, 6295-6299.
55. Swaneck,G.E. and Fishman,J. (1988) Covalent binding of the endogenous estrogen16α-hydroxyestrone to estradiol receptor in human breast cancer cells: Characterization and intranuclear localization. Proc. Natl Acad. Sci. USA, 85, 7831-7835.
56. Bradlow,H.L., Michnovicz,J.J., Telang,N.T. and Osborne,M.P. (1991) Effects of dietary indole-3-carbinol on esradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis, 12, 1571-1574.
57. Grubbs,C.J., Steel,V.E., Casebolt,T., Juliana,M.M., Eto,I., Whitaker,L.M., Dragnev,K.H., Kelloff,G.J. and Lubet,R.L. (1995) Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res., 15, 709-716.